Steris PLC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE

29 May 2026

STE

10-K: STERIS Fiscal 2026 Annual Results

STERIS reports strong fiscal 2026 growth with revenues rising 8.7% to $5.94 billion, driven by volume and pricing gains.

NYSE

29 May 2025

STE

Steris PLC

10-K: STERIS plc Reports Strong Fiscal 2025 Revenue Growth and Significant Debt Reduction Following Dental Segment Divestiture

STERIS plc announced a 6.2% increase in total revenues to $5.46 billion for fiscal year 2025, driven by robust performance in its Healthcare and Applied Sterilization Technologies segments, alongside a substantial reduction in debt after the sale of its Dental business.

NYSE

29 May 2024

STE

Steris PLC

10-K: STERIS plc Files 10-K Report, Details Financial Performance and Strategic Initiatives

STERIS plc's annual 10-K filing reveals a 13.3% revenue increase, strategic acquisitions, and a planned divestiture, alongside detailed financial results and risk factors.